NCRM Director Recruitment, Staff Hires, and IRP Training
NCRM Director Recruitment, Staff Hires, and IRP Training
批准号:
8158318
负责人:
John O'Shea
金额:
$40.01万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
中文摘要
国立卫生研究院再生医学中心(NCRM)是由共同基金支持的校内方案中的一项新倡议。NCRM的目标是在诱导多能干细胞(IPSC)技术和翻译应用方面奠定卓越的基础。这一设施将嵌入NIH IRP,并将利用与这项强大技术的开发和临床应用相关的实质性专业知识。该中心将由一名即将招募/确定的诱导性多能性细胞生物学的国际领导者领导,并将在NIH内壁计划内作为多个IC再生科学的中心。重点将放在iPS细胞的潜在临床应用上,利用NCGC的高通量能力和NIH临床中心提供的独特临床研究机会。NIPC将作为iPS细胞技术的卓越中心,开发实验工具和它产生的谱系的存储库,并提供质量控制和标准,从而使更广泛的研究社区受益,并推进个性化医学。
NCRM的首要目标之一是招聘和聘用一名董事。在2010财年,NCRM还聘请了两名全职工作人员开始这一过程。主任职位的广告已经公布,一个遴选委员会已经成立,候选人已经接受面试。除了招聘董事和招聘员工外,NCRM还在内部计划中努力加强IPSC研究。NCRM签约提供一个培训课程,使IRP成员能够开始生成IPSC。
英文摘要
The NIH Center for Regenerative Medicine (NCRM)represents a new initiative within the intramural program, which is supported by the Common Fund. NCRM aims to be a foundation for excellence in induced pluripotent stem cell (iPSC) technology and translational applications. This facility will be embedded within the NIH IRP and will capitalize on the substantive expertise relevant to the development and clinical applications of this powerful technology. The Center will be led by a to-be-recruited/identified international leader in iPS cell biology, and will serve as a focal point for regenerative science in multiple ICs within the NIH Intramural Program. Emphasis will be on potential clinical applications of iPS cells, capitalizing upon the high throughput capabilities of the NCGC and the unique clinical research opportunities provided by the NIH Clinical Center. The NiPC will serve as hub of excellence in iPS cell technology, develop experimental tools and a repository for the lines it generates, and provide quality control and standards, thereby benefitting the broader research community and advancing personalized medicine.
One of the first goals of the NCRM is to recruit and hire a Director. In FY10, NCRM also hired two full time staff members to begin this process. The Director position has been advertised, a Search Committee has been established, and candidates have been interviewed. In addition to Director recruitment and staff hires, NCRM has put effort into enhancing iPSC research in the intramural program. NCRM contracted to offer a training course to allow IRP members to begin generating iPSCs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytokine Signaling and Primary Immunodeficiency
-
批准号:8746512
-
项目类别:
-
资助金额:$16.68万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8939413
-
项目类别:
-
资助金额:$37.59万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine Signaling and Primary Immunodeficiency
-
批准号:8344727
-
项目类别:
-
资助金额:$19.16万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
MAP3K8 in immunoregluation, host defense and autoimmunity
-
批准号:7964945
-
项目类别:
-
资助金额:$26.71万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:7964897
-
项目类别:
-
资助金额:$26.71万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
MAP3K8 in immunoregluation, host defense and autoimmunity
-
批准号:8157152
-
项目类别:
-
资助金额:$26.81万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8157151
-
项目类别:
-
资助金额:$184.96万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:9360989
-
项目类别:
-
资助金额:$27.48万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:9360990
-
项目类别:
-
资助金额:$233.57万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:10712572
-
项目类别:
-
资助金额:$24.48万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine Signaling and Primary Immunodeficiency
-
批准号:10019961
-
项目类别:
-
资助金额:$24.3万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Janus kinases in the treatment of autoimmune disease
-
批准号:10265198
-
项目类别:
-
资助金额:$35.45万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine signaling, immunoregulation and autoimmune disease
-
批准号:10271324
-
项目类别:
-
资助金额:$319.04万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8939426
-
项目类别:
-
资助金额:$319.54万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:9155471
-
项目类别:
-
资助金额:$275.7万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Cytokine signaling, immunoregulation and autoimmune disease
-
批准号:10712574
-
项目类别:
-
资助金额:$220.34万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Mechanisms of gene expression and recombination
-
批准号:10928536
-
项目类别:
-
资助金额:$135.08万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8157134
-
项目类别:
-
资助金额:$26.81万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Targeting Jak3 in the treatment of autoimmune disease
-
批准号:8746493
-
项目类别:
-
资助金额:$6.67万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
Stat transcription factors in immunoregulation and autoimmune disease
-
批准号:8746508
-
项目类别:
-
资助金额:$310.29万
-
财政年份:--
-
负责人:John O'Shea
-
依托单位:
海外基金